I’m looking for education in
Neurology


Webcast
1.00 AMA PRA
Overcoming Obstacles: Agitation in Alzheimer's Disease


Webcast Series
1.50
CME/CE
Making the Call in Alzheimer’s Disease


0.75 CME/CE
Top 10 Questions on Biomarkers in Early Alzheimer’s Disease


1.00 CME/CE
Raising the Bar in ATTR Amyloidosis


Webcast
1.00 AMA PRA
Overcoming Obstacles: Agitation in Alzheimer's Disease
Treatment of Agitation Associated With Dementia Due to Alzheimer’s Disease
Faculty: | Anton P. Porsteinsson, MD |
Release: | 11/21/2024 |
Expiration: | 11/21/2025 |


Webcast Series
1.50 CME/CE
Making the Call in Alzheimer’s Disease
Course 1: | First Steps Toward Early Diagnosis of MCI or AD |
Course 2: | When Is It Time to Refer to a Neurologist |
Course 3: | Educating Patients and Caregivers About Targeted Therapies for Early AD |
Course 4: | Is the Patient a Candidate for an Antiamyloid Targeted Therapy? |
Course 5: | Managing AEs of Antiamyloid Therapies |
Course 6: | Updates to Clinic Infrastructure and Protocols |


0.75 CME/CE
Top 10 Questions on Biomarkers in Early Alzheimer’s Disease
Improving Diagnosis and Use of Targeted Therapies
Faculty: | R. Scott Turner, PhD, MD, FANA, FAAN; James E. Galvin, MD, MPH |
Release: | 03/28/2024 |
Expiration: | 03/28/2025 |


1.00 CME/CE
Raising the Bar in ATTR Amyloidosis
A Training Set on Diagnosis and Treatment
Faculty: | Julian D. Gillmore, MD, PhD; Sami Khella, MD |
Release: | 03/22/2024 |
Expiration: | 03/22/2025 |